Inventor · disambiguated record
Julie Nicole Hamblin
Also filed as: HAMBLIN JULIE N · HAMBLIN JULIE NICOLE
31 granted patents·21 pending applications·188 citations·filing 2002–2021
96Inventor score
Files withGLAXO GROUP LTD19HAMBLIN JULIE NICOLE9BALDWIN IAN ROBERT7GLAXOSMITHKLINE IP DEV LTD7ANIMA BIOTECH INC3
Top patents by PatentIndex Score
52 records- 0197US8586583B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·52 cites·7 claims
- 0292US8163743B24-carboxamide indazole derivatives useful as inhibitors of PI3-kinasesBALDWIN IAN ROBERT·Filed 2009·Granted Apr 24, 2012·43 cites·11 claims
- 0390US10383879B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Aug 20, 2019·4 cites·8 claims
- 0489US9353098B2Polymorphs and saltsGLAXO GROUP LTD·Filed 2015·Granted May 31, 2016·4 cites·3 claims
- 0589US8609657B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Dec 17, 2013·6 cites·11 claims
- 0688US9326987B2Indazole derivatives for use in the treatment of influenza virus infectionHAMBLIN JULIE NICOLE·Filed 2011·Granted May 3, 2016·5 cites·3 claims
- 0788US8575162B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 5, 2013·6 cites·7 claims
- 0887US8586590B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·5 cites·11 claims
- 0987US8580797B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 12, 2013·5 cites·8 claims
- 1086US9102668B2Polymorphs and saltsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Aug 11, 2015·3 cites·4 claims
- 1186US7226929B2Pyrrolidin-2-one derivatives as inhibitors of factor xaSMITHKLINE BEECHAM CORP·Filed 2006·Granted Jun 5, 2007·4 cites·11 claims
- 1283US7282497B2Pyrrolidin-2-one derivatives as inhibitors of factor xaGLAXO GROUP LTD·Filed 2006·Granted Oct 16, 2007·2 cites·12 claims
- 1380US8735390B2Polymorphs and saltsHAMBLIN JULIE NICOLE·Filed 2011·Granted May 27, 2014·5 cites·3 claims
- 1479US7566786B2Quinoline derivatives as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jul 28, 2009·14 cites·23 claims
- 1578US7528148B2Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2003·Granted May 5, 2009·14 cites·52 claims
- 1676US8993576B26-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereofHAMBLIN JULIE NICOLE·Filed 2011·Granted Mar 31, 2015·3 cites·4 claims
- 1774US10624898B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Apr 21, 2020·0 cites·8 claims
- 1874US7084139B2Pyrrolidin-2-one derivatives as inhibitors of factor XaSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 1, 2006·4 cites·11 claims
- 1972US10946025B2CompoundsGLAXO GROUP LTD·Filed 2020·Granted Mar 16, 2021·0 cites·6 claims
- 2072US8524751B24-oxadiazol-2-YL-indazoles as inhibitors of P13 kinasesHAMBLIN JULIE NICOLE·Filed 2010·Granted Sep 3, 2013·3 cites·9 claims
- 2170US7465743B2Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitorsGLAXO GROUP LTD·Filed 2005·Granted Dec 16, 2008·1 cites·24 claims
- 2270US7186717B2Pyrrolidine derivatives as Factor Xa inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Mar 6, 2007·4 cites·13 claims
- 2369US8765743B2CompoundsBALDWIN IAN ROBERT·Filed 2009·Granted Jul 1, 2014·1 cites·10 claims
- 2469US2018325911A1Novel compoundsGLAXO GROUP LTD·Filed 2018·Application pending·0 cites
- 2567US2014080830A1Novel CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2013·Application pending·0 cites
- 2666US2017157136A1Novel compoundsGLAXO GROUP LTD·Filed 2017·Application pending·0 cites
- 2764US2017015656A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 2861US10793559B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 6, 2020·0 cites·3 claims
- 2961US2015328226A1Novel CompoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 3060US2009312325A1Quinoline Derivatives As Phosphodiesterase InhibitorsBALDWIN IAN ROBERT·Filed 2009·Application pending·0 cites
- 3159US7517879B2Pyrrolidine derivatives as factor Xa inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Apr 14, 2009·0 cites·18 claims
- 3259US7429587B2Pyrrolidine derivatives as factor Xa inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Sep 30, 2008·0 cites·14 claims
- 3359US7326785B2Pyrrolidine derivatives as factor XA inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Feb 5, 2008·0 cites·3 claims
- 3456US2008132536A1Pyrazolo [3,4-b] pyridine compounds, and their use as pde4 inhibitorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3556US2016237073A1Novel Polymorphs and SaltsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 3655US2008175914A1Pyrazolo[3,4-b]Pyridine Compounds, and their Use as Phosphodiesterase InhibitorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3753US10457674B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Oct 29, 2019·0 cites·9 claims
- 3850US8658635B2Benzpyrazol derivatives as inhibitors of PI3 kinasesBALDWIN IAN ROBERT·Filed 2009·Granted Feb 25, 2014·0 cites·11 claims
- 3949US2006089375A1Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitorsALLEN DAVID G·Filed 2003·Application pending·0 cites
- 4046US2023212131A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 4146US2023150980A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 4245US2023116201A1Collagen 1 translation inhibitors and methods of use thereofANIMA BIOTECH INC·Filed 2021·Application pending·0 cites
- 4344US2016256466A1Pi3k inhibitor for treatment of respiratory diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 4444US2016263109A1P13k inhibitor for treatment of respiratory diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 4543US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 4642US7230114B2Intermediates for preparing neuraminidase inhibitor conjugatesBIOTA SCIENT MANAGEMENT·Filed 2002·Granted Jun 12, 2007·0 cites·36 claims
- 4741US2008021058A1Pyrazolo '3,4-B! Pyridine Compounds And Their Use As Phosphodiesterase Type 4(Pde4) InhibitorsALLEN DAVID G·Filed 2005·Application pending·0 cites
- 4839US11555040B2Oxepinopyrazole derivatives as inhibitors of P13-kinase activityGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jan 17, 2023·0 cites·13 claims
- 4937US2007161673A1P38 kinase inhibitorsBARKER MICHAEL D·Filed 2005·Application pending·0 cites
- 5035US2012245171A1Benzpyrazole derivatives as inhibitors of pi3 kinasesBALDWIN IAN ROBERT·Filed 2010·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →